Odyssey Therapeutics, Inc.
3 private offerings reported to the SEC on Form D since 2016, $499.2M sold in all. Biotech, MA.
- Form D offerings: 3
- Reported sold: $499.2M
- Newest: Dec 4, 2025
Every Form D Offering
Newest first; an amended notice updates the amount sold. Each filing opens on EDGAR.| Dec 4, 2025 | $214.0M | $214.0M | Odyssey Therapeutics, Inc.Biotech · MA | Not amended | 0001104659-25-118426 |
| Dec 15, 2023 | $117.2M | $121.1M | Odyssey Therapeutics, Inc.Biotech · MA | Aug 14, 2024 | 0001882782-23-000001 |
| Oct 27, 2022 | $168.0M | $174.9M | Odyssey Therapeutics, Inc.Biotech · MA | Not amended | 0001882782-22-000002 |
SEC Profile
From the company's EDGAR record- Ticker
- ODTX
- Business address
- Boston, Ma
- Incorporated in
- DE
- SEC industry
- Biological Products, (No Diagnostic Substances)
- All SEC filings
- CIK 1882782 on EDGAR
A Form D reports the amount offered and sold so far in a private offering, not who invested or at what valuation. Shares issued in a merger are left out. The profile is read from EDGAR daily. SEC Form D data sets and EDGAR